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ABSTRACT: 
Although many studies have shown the antitumor properties of ginger extract (Zingiber officinale), little 
is known regarding the mechanism of its effects. This study was conducted to determine the mechanism 
of antitumor effects of ginger extract by evaluating apoptosis rate and cell cycle progression status in 
colon cancer cell lines HCT 116 and p53 defective HT 29. HCT 116 and HT 29 cells were cultured in the 
presence of ginger extract at various concentrations for 24 h. The percentage of cell viability was 
determined by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-di phenyl tetrazolium bromide (MTT) assay. Our results 
showed that ginger extract inhibited proliferation of HCT 116 and HT 29 cells with an IC50 of 496 ± 34.2 
µg/ml and 455 ± 18.6 µg/ml, respectively. We also found that ginger extract at increasing concentrations 
induced apoptosis dose dependently in both colon cancer cells. Apoptosis rates were 11.15, 35.05 and 
57.49% for HCT 116 and 4.39, 19.81 and 28.09% for HT 29 at 200, 500 and 800 µg/ml of ginger extract, 
respectively. Ginger extract arrested HCT 116 and HT 29 cells at G0/G1 and G2/M phases with 
corresponding decreased in S-phase. This study suggests that ginger extract may exert its antitumor 
effects on colon cancer cells by suppressing its growth, arresting the G0/G1-phase, reducing DNA 
synthesis and inducing apoptosis. 
